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H I G H L I G H T S
• Electronic von Frey test is useful to evaluate movement-induced muscle pain.
• Intense acute swimming can be used as a model of delayed onset muscle soreness.
• Targeting TNF-α/TNFR1 reduced DOMS as well as DOMS induces TNF-α production.
• TNF-α production occurs in the periphery (soleus muscle) and spinal cord.
• Targeting TNF-α/TNFR1 reduced inﬂammation, oxidative stress and pain.⁎ Corresponding author at: Departamento de Patolo
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Oxidative stressThe injection of cytokines such as TNF-α induces muscle pain. Herein, it was addressed the role of endogenous
TNF-α/TNFR1 signaling in intense acute swimming-induced muscle mechanical hyperalgesia in mice. Mice
were exposed towater during 30 s (sham)or to a single session of 30–120min of swimming. Intense acute swim-
ming induced a dose-dependent (time of exercise-dependent) muscle mechanical hyperalgesia, which peaked
after 24 h presenting characteristics of delayed onset muscle soreness (DOMS). The intense acute swimming
(120 min)-induced muscle mechanical hyperalgesia was reduced in etanercept (soluble TNF receptor) treated
and TNFR1 deﬁcient (−/−) mice. TNF-α levels increased 2 and 4 h after intense acute swimming in soleusmuscle
(but not in gastrocnemius), and spinal cord, respectively. Exercise induced an increase ofmyeloperoxidase activ-
ity and decrease in reduced glutathione levels in an etanercept-sensitive and TNFR1-dependent manners in the
soleus muscle, but not in the gastrocnemius muscle. Concluding, TNF-α/TNFR1 signaling mediates intense acute
swimming-inducedDOMSby an initial role in the soleusmuscle followed by spinal cord, inducingmuscle inﬂam-
matory hyperalgesia and oxidative stress. The knowledge of these mechanismsmight contribute to improve the
training of athletes, individuals with physical impairment and intense training such as military settings.
© 2014 Elsevier Inc. All rights reserved.1. Introduction
Long term aerobic physical training with mild to moderate intensity
(20–30 min) is able to reduce inﬂammatory and neuropathic pain in
animal models [1–4]. However, intense acute physical exercise of mod-
erate intensity and long duration can induce allodynia and hyperalgesiagia, Universidade Estadual de
86.051-990, Cx Postal 6001,
5 43 3371 4387.
om.br (W.A. Verri).
ID: I-1330-2013; Scopus Authorpost-exercise. Furthermore, eccentric physical exercise and forced
swimming, respectively, are capable of inducing mechanical and
thermal hyperalgesia, and chronic muscle pain [5–7].
Previous studies have linked chemical mediators such as cytokines
with pro-inﬂammatory characteristics to the genesis of pain [8–10]. Ad-
ditionally, the acute physical exercise has also been linked to signaling
pathways related to cytokines in post-exercise [5,11]. TNF-α has an
early pivotal role in the development of hyperalgesia, activating two
hyperalgesic pathways IL-1β-induced prostaglandin production and
IL-8-induced sympathetic amines release in the carrageenan model of
inﬂammatory hyperalgesia [8]. In line with a role of TNF-α in muscle
pain, the intramuscular injection of TNF-α evokes a time- and dose-
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dicating a possible critical role of TNF-α in the development of muscle
hyperalgesia [10]. In agreement, TNF receptor I and II are expressed in
skeletal muscle [12]. Moreover, horses submitted to high intensity
exercise present elevated levels of TNF-α in blood and skeletal muscle
samples [13].
The time course of cytokine production in skeletal muscle after
intense exercise is related with the muscle damage, and it is probable
that myocytes are mechanically damaged during the strenuous exer-
cise, and this lesion stimulates the local production of inﬂammatory
cytokines including TNF-α [14].
TNF-α also coordinates the recruitment of neutrophils to inﬂamma-
tory foci as well as activates nicotinamide adenine dinucleotide
phosphate-oxidase (NADPHoxidase) resulting in superoxide anion pro-
duction and consequent oxidative stress [15–18]. In fact, intense and
prolonged physical exercise can result in oxidative damage of proteins
and lipids present in contractile myocytes. High levels of reactive
oxygen species can promote contractile dysfunction resulting in muscle
weakness and fatigue [19]. Moreover, reactive oxygen species may
modulate signaling pathways and regulate the expression of multiple
genes, including cytokines. In this sense, cytokines and oxidative stress
are interdependent pathways [20] involved inmuscle inﬂammation and
pain.
Taking into account the abovementioned and that TNF-α is themost
clinically consolidated cytokine target, in the present study it was
addressed the role of endogenous TNF-α in the development of intense
acute swimming-induced muscle mechanical hyperalgesia in mice,
which presents characteristics of delayed onset muscle soreness.
TNFR1 deﬁcient (−/−) mice and intraperitoneal (i.p.) treatment with
etanercept (soluble TNF receptor) were used to evaluate the participa-
tion of TNF-α in the mechanisms of intense acute swimming-induced
muscle pain. Additionally, TNF-α production was investigated in pe-
ripheral and spinal sites as well as its inﬂuence in muscle inﬂammation
(myeloperoxidase activity) and oxidative stress (reduced glutathione
levels).
2. Materials and methods
2.1. Animals
The experiments were performed on male C57BL/6 (wild type —
WT) and TNFR1 deﬁcient (−/−) mice, 20–25 g from University of São
Paulo, Ribeirão Preto, SP, Brazil. Mice were housed in standard clear
plastic cages with free access to water and food, light/dark cycle of
12/12 h and controlled temperature.Miceweremaintained in the vivar-
ium of the Department of Pathology of Universidade Estadual de
Londrina for at least two days before experiments. Mice were used
only once and were acclimatized to the testing room at least 1 h before
the experiments, which was conducted during the light cycle. Animals'
care andhandling procedureswere in accordancewith the International
Association for Study of Pain (IASP) guidelines and with the approval
of the Institutional Ethics Committee for Animal Research of the
Universidade Estadual de Londrina, process number 2066.2011. All
efforts were made to minimize the number of animals used and their
suffering.
2.2. Intense acute swimming
Micewere placed in a glass box (45×28×25 cm, divided in six com-
partments) with approximately 20 l of water at 31° ± 1 °C [21]. Each
mouse was placed in one compartment and swam all the same time.
A drop of liquid soap was added to reduce the surface tension of
water diminishing the “ﬂoating” behavior [2]. After the intense acute
swimming session or sham conditions, animals were dried and placed
in cages together with their respective group. Mice were randomized
in sham and exercised groups. Sham animals were allowed to swimfor just 30 s, and were immediately removed from the water after this
period and dried. Mice in the swimming group were exposed to water
for 1 session of 30, 60 or 120 min, or 1 session of 30min per day during
5 days. Themechanical hyperalgesia was evaluated between 6 and 48 h
after the swimming session. Intense acute swimming session of 120min
was recorded using a digital camera and time spent swimming was de-
termined individually. The results were expressed as themean± S.E.M.
of swimming time.2.3. Evaluation of mechanical hyperalgesia
Mechanical hyperalgesia was tested in mice as previously reported
[22,23]. Brieﬂy, in a quiet room, mice were placed in acrylic cages
(12 × 10 × 17 cm) with wire grid ﬂoors, 15–30 min before the start of
testing. The test consisted of evoking a hind paw ﬂexion reﬂex with a
hand-held force transducer (electronic von Frey anesthesiometer; In-
sight, Ribeirão Preto, SP, Brazil) adaptedwith a 0.5 or 4.15mm2 (referred
to as regular and large probes, respectively) contact area polypropylene
tips [22,23]. The investigator was trained to apply the probes perpendic-
ularly to the central area of the hind paw with a gradual increase in
pressure. The end point was characterized by the removal of the paw
followed by clear ﬂinching movements. After the withdrawal response,
the intensity of the pressure was recorded automatically. The value for
the response was an average of three measurements. The animals were
evaluated at baseline and between 6 and 48 h after exercise. The results
are expressed by delta (Δ) withdrawal threshold (in g) calculated by
subtracting the mean measurements (indicated time points) after stim-
ulus from the baseline measurements. The basal mechanical withdrawal
threshold was 8.8 ± 0.1 g (mean ± S.E.M. of 29 groups, 6 mice per
group) before the intense acute swimming session. There was no
difference of basal mechanical withdrawal thresholds between groups
in the same experiment.2.4. Cortisol and glucose plasmatic concentrations
The animals were anesthetized with ethyl ether and blood samples
of all groups were collected from ocular orbit immediately after (2 h)
and 24 h after the intense acute swimming session, always in the
afternoon (between 15:00 h and 17:00 h). Samples were centrifuged
at 3.300 g in 4 °C for 5 min and the plasma resultant was assayed for
cortisol and glucose levels. Cortisol was evaluated by Architect System
Kit, which is a chemiluminescent assay of microparticles for quantita-
tive determination of serum cortisol and glucose concentrations
(Dimension® Clinical Chemistry System — SIEMENS) was quantiﬁed
with spectrophotometer both according to the manufacture's guide-
lines. Naïve and sham groups were used as control.2.5. Leukocyte migration to the skeletal muscle tissue
The intense acute swimming-induced leukocyte recruitment to
the soleus and gastrocnemius muscles of mice was evaluated using
the myeloperoxidase (MPO) kinetic–colorimetric assay [24]. Sam-
ples of skeletal muscles were collected in 50 mM K2HPO4 buffer
(pH 6.0) containing 0.5% hexadecyl trimethylammonium bromide
(HTAB) and kept at −86 °C until use. Samples were homogenized
using a Polytron (PT3100), centrifuged at 16.100 g in 4 °C for 2 min
and the resulting supernatant assayed spectrophotometrically
for MPO activity determination at 450 nm (Spectra max), with 3
readings in 1 min. The MPO activity of samples was compared to a
standard curve of neutrophils. Brieﬂy, 10 μl of sample were mixed
with 200 μl of 50 mM phosphate buffer pH 6.0, containing
0.167 mg/ml O-dianisidine dihydrochloride and 0.0005% hydrogen
peroxide. The results were presented as MPO activity (number of
total neutrophils x 1010/mg of muscle).
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Mice were killed 2 and 4 h after swimming session and samples of
the spinal cord (L4–L6), and gastrocnemius and soleus muscles were
collected. The samples were homogenized in 300 μl (spinal cord pool
of threemice) or 500 μl (skeletalmuscles) of the appropriate buffer con-
taining protease inhibitors. TNF-α level was determined as described
previously [25] by enzyme-linked immunosorbent assay (ELISA). The
resultswere expressed as picograms (pg) of TNF-α per 100mgof tissue.
Naïve and sham groups were used as control.
2.7. Reduced glutathione (GSH) assay
The levels of skeletal muscle GSH were determined using a spectro-
photometricmethod [26]. Samples of gastrocnemius (100mg) or soleus
(40mg) (1:10 dilution)were homogenized (IKA T10) in 4 and 1.6ml of
EDTA 0.02 M, respectively. Homogenates (2.5 ml) were treated with
2 ml H20 Milli Q plus 0.5 ml of trichloroacetic acid 50%. After 15 min,
the homogenates were centrifuged at 1500 g for 15 min, and 1 ml
from supernatant was added to 2 ml of a solution containing Tris 0.4
M (pH 8.9) plus 50 ml of DTNB. After 5 min, the measurements were
performed in 412 nm against white control (UV–Visible spectropho-
tometer [UV-1650 PC] — SHIMADZU). The GSH levels were corrected
according to the total protein concentration. The results were presented
as mmols of GSH per gram of protein in skeletal muscles.
2.8. Drugs
Drugs were obtained from the following sources: Carrageenan
(100 μg diluted in 25 μl of NaCl 0.9%/mice) from FMC (Philadelphia),
2% lidocaine chloride without vasoconstrictor (5 μl) from Cristalia (São
Paulo, Brazil), etanercept (1–10 mg/kg diluted in NaCl 0.9%/mice)
from Wyeth (São Paulo, Brazil) and saline solution 0.9% from Gaspar
Viana S/A (Fortaleza, CE, Brazil).
2.9. Statistical analysis
Results are presented as means ± S.E.M. of measurements made on
6 mice in each group. Two-way analysis of variance (ANOVA) was used
to compare the groups and doses at all times (curves) when the
hyperalgesic responses were measured at different times after the ad-
ministration or enforcement of the stimuli. The analyzed factors were
treatments, time and time versus treatment interaction. When there
was a signiﬁcant time versus treatment interaction, one-way ANOVA
followed by Tukey's t-test was performed for each time. On the other
hand, when the hyperalgesic response were measured once after the
administration or enforcement of the stimuli, the difference between
responses were evaluated by one-way ANOVA followed by Tukey's
t-test. Additionally, comparative statistical analysis between two groups
were done using t test. Statistical differences were considered to be
signiﬁcant at P b 0.05.
3. Results
3.1. Evaluation of swimming intensity to induce mechanical hyperalgesia
In the ﬁrst series of experiments, it was investigated the appropriate
swimming time to induce mechanical hyperalgesia and its temporal
proﬁle. Mice were submitted to swimming sections of 30 min once a
day during 5 days (Fig. 1A). There was no evidence of mechanical
hyperalgesia in these mice compared to sham group. The mechanical
hyperalgesia was measured every day, but only the data of the 5th
day is presented for clarity (Fig. 1A). Using a different protocol, mice
were submitted to a single session of 30, 60 or 120 min of swimming
(Fig. 1B). Again, 30 min did not induce mechanical hyperalgesia. On
the other hand, the 60 and 120 min of swimming induced signiﬁcantmechanical hyperalgesia at 6, 12 and 24h after exercise. Themechanical
hyperalgesia induced by 120 min of exercise remained signiﬁcant up to
48 h with signiﬁcant differences compared to 30 and 60 min at 24 and
48 h after exercise (Fig. 1B). The peak of hyperalgesia was observed at
24 h after swimming session. Therefore, 120 min swimming session
and evaluations at 24 h were chosen for next experiments.
In the next set of experiments, lidocaine 2% was injected
intraplantarly (i.pl., 5 μl) [23] or intramuscularly (i.m., 20 μl, in the
calf). The i.pl. injection of lidocaine increased the mechanical threshold
of sham group resulting in a negative delta of reaction (Fig. 1C). On the
other hand, the control swim group presented signiﬁcant mechanical
hyperalgesia, which was unaffected by i.pl. treatment with saline
or lidocaine or i.m. treatment with saline (Fig. 1C). Intense acute
swimming-induced mechanical hyperalgesia was reduced by i.m. (in
the calf) treatment with lidocaine. To conﬁrm that the lack of effect of
i.pl. lidocaine in intense acute swimming-induced muscle mechanical
hyperalgesia is shared by other types of muscle pain, mice were treated
with saline or lidocaine 2% (i.pl., 5 μl) 4.5 h after carrageenan (100 μg)
[27] or saline (20 μl) injection in the calf (i.m.) (Fig. 1D). I.pl. lidocaine
increased the mechanical threshold of mice that received i.m. saline,
but did not affect the mechanical threshold of carrageenan group
(Fig. 1D) while i.m. lidocaine reduced carrageenan-induced muscle
mechanical hyperalgesia (Fig. 1D). Thus, conﬁrming that intense
acute swimming- and i.m. carrageenan-induced muscle mechanical
hyperalgesia depends on movement-elicited hyperalgesia rather than
cutaneous paw hyperalgesia.
3.2. Involvement of TNF-α/TNFR1 in the muscle mechanical hyperalgesia
induced by intense acute swimming
In this set of the experiments, two area size probes were used
0.5 mm2 (regular probe, Fig. 2A and C) and 4.15 mm2 (large probe,
Fig. 2B and D). Intense acute swimming (120 min) induced signiﬁcant
muscle mechanical hyperalgesia in WT (wild type — C57BL/6) mice
compared to sham group as determined using both probes (Fig. 2A–
D). The treatment with etanercept (soluble TNF receptor) inhibited in
a dose-dependent manner (1–10 mg/kg, i.p., 48 and 1 h before the ses-
sion, Fig. 2A and B) the intense acute swimming-induced muscle
hyperalgesia. The 10 mg/kg dose was effective in inhibiting intense
acute swimming-induced muscle mechanical hyperalgesia from 6th to
36th h with the regular probe (Fig. 2A) and from 6th to 48th with the
large probe (Fig. 2B) with signiﬁcant differences compared to the
lower doses of etanercept between 6 and 24 h with the regular probe
(Fig. 2A) and 6–36 hwith the large probe (Fig. 2B). Additionally, intense
acute swimming-induced muscle mechanical hyperalgesia was almost
abolished between 6th to 48th h in TNFR1 deﬁcient (−/−) mice com-
pared toWT(C57BL/6) (Fig. 2C andD) as determined using both probes.
There was no statistical difference between sham groups of WT and
TNFR1−/− mice (data not shown). Thus, these results indicate that
TNF-α acting on TNFR1 receptor is an important cytokine in intense
acute swimming-induced muscle mechanical hyperalgesia. There
was no difference in the total swimming time over 120 min of
WT, TNFR1−/− and WT mice treated with etanercept (10 mg/kg)
(103.81 ± 3.46; 105.15 ± 7.73; and 102.41 ± 3.29 min, respectively;
n= 6, P N 0.05).
3.3. Intense acute swimming induces the production of TNF-α in the spinal
cord and soleus, but not in the gastrocnemius muscle
The levels of TNF-α produced upon intense acute swimming were
measured in the soleus (Fig. 3A) and gastrocnemius (Fig. 3B) skeletal
muscles and spinal cord (L4–L6, Fig. 3C) 2 and 4 h after exercise session.
There was signiﬁcant increase of TNF-α levels in the soleus muscle 2 h
after intense acute swimming, but basal levels were detected 4 h after
exercise session (Fig. 3A). On the other hand, there was no difference
between naïve, sham and intense acute swimming groups regarding
Fig. 1. Time of swimming-dependent mechanical hyperalgesia. WT mice were submitted to one daily swimming session of 30 min over 5 days (Panel A, only the ﬁfth day results were
presented) or to one session of intense acute swimming of 30, 60 or 120min (Panel B). Themechanical hyperalgesiawas evaluated 6–48 h after each session. Lidocaine or vehicle (saline)
was injected i.pl. (5 μl) or i.m. (20 μl) 30min before themeasurements of intense acute swimming groups (24th h after the session) (Panel C), or intramuscular injection of saline (20 μl) or
carrageenan (100 μg) groups (5th h after the stimuli) (panel D). Results are presented as means± S.E.M. of 6mice per group, and are representative of 2 separated experiments. Panel B:
*P b 0.05 comparedwith the sham and intense acute swimming 30min; #P b 0.05 compared to sham and intense acute swimming 30 and 60min; Panel C: **Pb 0.05 comparedwith control
and lidocaine i.m. sham groups; ##P b 0.05 compared with sham groups; ***P b 0.05 compared with control, saline/lidocaine i.pl. and saline i.m.; Panel D: fP b 0.05 compared with saline
i.m./i.pl. and saline/lidocaine i.m.; ffP b 0.05 compared with saline i.m. groups; fffP b 0.05 compared with carrageenan i.m. groups (One-way ANOVA followed by Tukey's t test).
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increase of TNF-α (Fig. 3C) levels in the spinal cord 4 h, but not at 2 h
after exercise session. Thus, TNF-α is produced peripherally at an early
phase in the soleus muscle (Fig. 3A) and in a second moment in the
spinal cord (Fig. 3C).
3.4. Intense acute swimming induces TNF-α/TNFR1-dependent increase of
myeloperoxidase (MPO) activity in the soleus, but not in the gastrocnemius
muscle
Intense acute swimming induced signiﬁcant increase ofMPOactivity
in the soleus muscle at 24 h (peak of hyperalgesia) after the session
compared to naïve and sham groups (Fig. 4A). On the other hand, the
MPO activity achieved similar levels in naïve, sham and intense acuteswimming groups in the gastrocnemius muscle (Fig. 4B). Furthermore,
the intense acute swimming-induced increase of MPO activity was
reduced by etanercept treatment (10 mg/kg, i.p., 48 and 1 h before
the session) and in TNFR1−/−mice (Fig. 4C) in the soleus muscle, with-
out differences among groups in the gastrocnemius muscle (Fig. 4, D).
There was no statistical difference between naïve and sham groups of
WT and TNFR1−/−mice (data not shown).
3.5. Intense acute swimming induces TNF-α/TNFR1-dependent depletion of
endogenous reduced glutathione (GSH)
Intense acute swimming induced the reduction of GSH levels at 2
and 4 h after exercise session, which was detected in the soleus
(Fig. 5A), but not in the gastrocnemius muscle (Fig. 5B). Furthermore,
Fig. 2. Reduction of intense acute swimming-inducedmusclemechanical hyperalgesia in etanercept treated and TNFR1−/−mice.Micewere exposed to sham conditions (30 s exposure to
water) or intense acute swimming for 120min. The intensity of mechanical hyperalgesia was evaluated 6–48 h after the session in etanercept treated (1–10 mg/kg, i.p., 48 and 1 h before
the session, Panels A and B) and TNFR1−/−mice (Panels C andD). Results are presented asmeans± S.E.M. of 6mice per group, and are representative of 2 separated experiments. *Pb 0.05
compared with sham; #P b 0.05 compared with controls [non-treated (Panels A and B) or WT (Panels C and D)]; **P b 0.05 compared with vehicle control (saline) and 1 mg/kg dose of
etanercept; ##P b 0.05 compared with vehicle control (saline), 1 and 3 mg/kg doses of etanercept (One-way ANOVA followed by Tukey's t test).
Fig. 3. Intense acute swimming induces TNF-α production in the soleus muscle and spinal cord, but not in the gastrocnemius muscle. WT mice were exposed to sham conditions (30 s
exposure to water) or received intense acute swimming for 120 min, and the levels of TNF-α in soleus (Panel A) and gastrocnemius (Panel B) muscles, and spinal cord (L4–L6) (Panel
C) were quantiﬁed, as determined by ELISA. The samples were collected immediately in the end (2 h) and 2 h after the exercise session (4 h). Results are presented as means ± S.E.M.
of 6 mice per group, and are representative of 2 separated experiments. *P b 0.05 compared with naive, sham and 4 h; #P b 0.05 compared with naive, sham and 2 h (One-way
ANOVA followed by Tukey's t test).
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Fig. 4. Intense acute swimming-induced increase in MPO activity was reduced by etanercept treatment and in TNFR1−/−mice in the soleus muscle and unaltered in the gastrocnemius
muscle. Mice were exposed to sham conditions (30 s exposure to water) or received acute swimming for 120 min. Samples were collected 24 h after the intense acute swimming and
the myeloperoxidase (MPO) activity was determined in the soleus and gastrocnemius muscles of WT (Panels A and B), etanercept treated (10 mg/kg, i.p., 48 and 1 h before the session)
and TNFR1−/− (Panels C and D)mice. Results are presented asmeans± S.E.M. of 6mice per group, and are representative of 2 separated experiments. *P b 0.05 comparedwith naive and
sham; #P b 0.05 compared with intense acute swimming positive control (One-way ANOVA followed by Tukey's t test).
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in the soleus muscle by etanercept treatment (dose as in Fig. 4) and in
TNFR1−/−mice (Fig. 5C)while the GSH levels were similar in all groups
in the gastrocnemius muscle (Fig. 5D). There was no statistical differ-
ence between naïve and sham groups of WT and TNFR1−/− mice
(data not shown). Thus, indicating that TNF-α acting on TNFR1 receptor
contributes to the oxidative stress in the soleus muscle induced by
intense acute swimming.
3.6. Evaluation of serum cortisol and glucose levels
To disprove that the present model is a stress-induced hyperalgesia
model, plasma cortisol and glucose levels were assessed. Two time
points were chosen, 2 h representing the immediately time the swim-
ming session ﬁnished and 24 h representing the peak of hyperalgesia.
One session of intense acute swimming did not increase cortisol
(Fig. 6A) and glucose (Fig. 6B) levels in WT mice at 2 or 24 h after theswimming session, presenting concentrations similar to the baseline
levels (naïve and sham groups). TNFR1−/−mice did not present chang-
es in the concentrations proﬁle of plasmatic cortisol (Fig. 6A) and
glucose (Fig. 6B) from WT mice, evidencing that TNFR1 deﬁciency
does not affect the release of cortisol or glucose in the present
experimental condition.4. Discussion
Moderate physical exercise of short duration carried out daily with
professional guidance is beneﬁcial and helps to control pain states in
patients with chronic diseases such as lupus, ﬁbromyalgia, rheumatoid
arthritis, and type 2 diabetes [28–31]. On the other hand, the present
study demonstrates that intense acute swimming induces prolonged
muscle mechanical hyperalgesia, muscle inﬂammation and oxidative
stress dependent on endogenous TNF-α activation of TNFR1 receptors.
Fig. 5. Intense acute swimming-induced depletion of endogenous GSH levels was reversed by etanercept treatment and in TNFR1−/−mice in the soleusmuscle but, not in the gastrocne-
mius muscle. Mice were exposed to sham condition (30 s expose to water) or received intense acute swimming for 120min. The samples of soleus and gastrocnemiusmuscles were col-
lected and endogenous reduced glutathione (GSH) levels was evaluated immediately after (2 h) and 2 h after (4 h) intense acute swimming in WT (Panels A and B), etanercept treated
(10 mg/kg, i.p., 48 and 1 h before the session) and TNFR1−/− (Panels C and D) mice. Results are presented as means ± S.E.M. of 6 mice per group, and are representative of 2 separated
experiments. *P b 0.05 compared to naive and sham; #P b 0.05 compared with intense acute swimming positive control (One-way ANOVA followed by Tukey's t test).
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reduction in the grip force test, increases the local inﬂammation and
mechanical hyperalgesia to muscle pressure while there was no alter-
ation in the response to von Frey hairs [9]. Schäfers et al. [9] injected
TNF-α in the gastrocnemiusmuscle, and in the present study it was de-
tected that intense acute swimming induces an increase of TNF-α levels
only in the soleus muscle. Here, we have detected muscle mechanical
hyperalgesia using an electronic version of von Frey method, which
presents differenceswith the analogmethod [9] sincewith the electron-
ic version there is a basal response indicating that the experiments are
measuring hyperalgesia, and in the analog version the majority of re-
search groups do not detect a basal response indicating that it is being
evaluated allodynia [22,32]. Therefore, these studies are evaluating dif-
ferent experimental conditions. Furthermore, an important question
that was raised in the development of this study was if this electronic
version of von Frey test could in addition to the known detection of
cutaneous hyperalgesia, also detect movement-elicited hyperalgesia.
To further elucidate this issue, lidocaine was injected i.pl. in micesubmitted to sham conditions, intense acute swimming or that received
i.m. injection of carrageenan. The i.pl. treatment with lidocaine in-
creased the mechanical cutaneous threshold of negative control groups
(saline i.m. and sham swim),which is consistentwith theprimary use of
this test as previously described [22]. On the other hand, animals sub-
jected to exercise or carrageenan-induced muscle inﬂammation
showed a reduction of mechanical threshold that was not affected by
i.pl. lidocaine. It is reasonable that mice with muscle hyperalgesia and
non-sensitized cutaneous paw tissue presents lower mechanical
threshold upon movement compared to cutaneous threshold, thus,
explaining why i.pl. lidocaine treatment did not affect muscle
hyperalgesia. Lidocaine was also injected i.m. (in the calf), and
this treatment was successful to inhibit intense acute swimming- and
carrageenan-induced mechanical hyperalgesia, indicating that
movement-elicited muscle hyperalgesia and muscle inﬂammatory
hyperalgesia were under investigation, respectively. Further addressing
the differentiation of cutaneous and muscle hyperalgesia, the modula-
tion of hyperalgesia was evaluated in WT mice treated with vehicle,
Fig. 6. Intense acute swimming did not induce increases in plasmatic concentrations of cortisol and glucose inWT and TNFR1−/−mice. Mice were exposed to sham condition (30 s expose
to water) or received intense acute swimming for 120min. Blood samples were collected immediately after 2 h and 24 h of intense acute swimming session for determination of plasma
concentrations of cortisol (Panel A) and glucose (Panel B) inWT and TNFR1−/−mice. Results are presented as means ± S.E.M. of 6 mice per group, and are representative of 2 separated
experiments. P N 0.05 (One-way ANOVA followed by Tukey's t test).
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area) that elicits nociceptive responses per se and large probe
(4.15 mm2 contact area) that does not elicit nociceptive responses per
se [23]. It was observed that similar results were obtained using both
probes. These results are in accordance with previous data which dem-
onstrate that large diameters probes provide estimation of muscular
pain thresholds [33]. The fact that we have succeeded in measuring
muscle painwith a 0.5mm2 diameter probewas due to intact cutaneous
paw tissue added to sensitized muscle tissue condition. Taking into ac-
count the experiments with lidocaine and two contact area probes, it
is conceivable that the pressure exerted by the probe on the plantar sur-
face induces the dorsal ﬂexion of the ankle joint, promoting the stretch
of the Achilles tendon, generating muscle distention (movement-elicit-
ed hyperalgesia), which is sufﬁcient to trigger muscle nociceptive re-
sponses. It is possible that the paw withdrawal reﬂex of mice during
the nociceptive test may be a stretch reﬂex response resulting from ac-
tivation of muscle receptors related to muscle length (muscle spindles)
and/or ﬂexion reﬂex (removal of the member upon a painful stimulus)
in an attempt to avoid further damage to the already inﬂamed muscle
that worked excessively during the intense acute swimming session
[34–36]. Therefore, the decreased mechanical threshold observed
after swimming sessions was related to muscle and not cutaneous
hyperalgesia. Moreover, these data demonstrate a novel applicability
for the electronic von Frey test.
Targeting TNF-α in WT mice by treatment with etanercept dose-
dependently inhibited the intense acute swimming-induced muscle
mechanical hyperalgesia. In agreement with this pharmacological ap-
proach, TNFR1−/−mice also presented reduced hyperalgesia compared
toWTmice. Therefore, TNF-α acting on TNFR1 is an important cytokine
in intense acute swimming-induced muscle mechanical hyperalgesia.
There was no difference in the effectively swimming time of WT, WT
treated with etanercept, and TNFR1−/−mice indicating that the differ-
ence in the muscle hyperalgesia, and immune and biochemical param-
eters cannot be attributed to difference in the swimming time. The
importance of TNF-α is emphasized by the therapeutic approaches
targeting this cytokine in diseases. Pre-clinical studies have been
demonstrating the role of TNF-α in inﬂammatory hyperalgesia [8] and
that the TNFR1 receptor is of importance in carrageenan-, antigen-
and zymosan-induced mechanical hyperalgesia [10,37–39]. Targeting
TNF-α or TNFR1, but not TNFR2 also reduces experimental neuropathic
pain [40,41], which corroborates evidence that nerve injury in the
chronic constriction injury model induces the increased production of
TNF-α [42,43]. The production of TNF-α seems to be an early event inboth inﬂammation and nerve injury models [8,11,43]. It is likely that
the production of TNF-α is an early event in the soleusmuscle in the in-
tense acute swimming-inducedmuscle inﬂammation and hyperalgesia.
Moreover, in carrageenan-induced paw inﬂammation, TNF-α is also an
early cytokine [8,10]. In agreement with the present results, TNF-α
mRNA expression increased in response to formalin-inducedmuscle in-
ﬂammation [44]. In vivo evidence showed elevated levels of TNF-α in
the trapezius muscle of subjects with myofascial trigger points, linking
this cytokine with muscle painful and inﬂammatory conditions [45]. It
is noteworthy to mention that two treatments with etanercept
(25 mg/kg)with at least 6 weeks of interval apart did not alter themus-
cle pain (e.g. visual analog scale and pressure pain threshold) induced
by 4 sets of 15 repetitions at 80% of individual one-repetitionmaximum
using leg press [46]. Additionally, non-painful exercise induces an
increase in TNF-α mRNA expression [47]. However, these apparent
contradictions with our study might have some explanations. The
etanercept package insert recommends a dose of 25 mg twice a week
and advises that the effectiveness may be compromised by reduction
of dose or increase of treatment interval in humans [48], and in fact, in-
crease of effectiveness was observed with higher doses of etanercept
such as 50 mg twice a week [49,50]. In this line, in the present study a
dose–response curve was performed using 48 and 1 h of pretreatment
with etanercept as well as TNFR1−/− mice, which guaranteed proper
conditions to evaluate the role of TNF-α in intense acute swimming-
induced muscle mechanical hyperalgesia. Murase et al. [47] detected
an increase of TNF-α mRNA expression in non-painful exercise while
did not perform functional studies targeting TNF-α to reduce muscle
hyperalgesia in painful exercise. Herein, TNF-α protein levels were de-
termined and TNF-α and TNFR1 were target using pharmacological
and genetic tools, respectively. Importantly, pain evaluation method,
doses of treatments, exercise and muscle characteristics might have
inﬂuenced these different results.
Intense acute swimming induced an increase of TNF-α production in
the spinal cord at 4 h, which occurs after the increase of TNF-α produc-
tion in the soleus muscle, at 2 h. Furthermore, the time proﬁle of TNF-α
production at 2 h in the soleus muscle and at 4 h in the spinal cord sug-
gests that the peripheral TNF-αmay be responsible for the increase of
TNF-α production in the spinal cord. In this sense, it has been described
that the depolarization of primary afferent nociceptors induces the re-
lease of the chemokine CX3XL1 by neurons in the spinal cord, which
in turn, activates CX3CR1 receptors inmicroglia resulting inMAP (mito-
gen-activated protein) kinase p38 phosphorylation that induces TNF-α
production. TNF-α activates second order neurons in the spinal cord to
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central (spinal cord) integrated nociceptive mechanism in the patho-
physiology of intense acute swimming-induced muscle mechanical
hyperalgesia. The detection of muscle mechanical hyperalgesia at later
time points compared to the TNF-α production line up well with previ-
ous data demonstrating that TNF-α (10 μg) injection in the muscle in-
duces mechanical hyperalgesia peaking at 12 h [9]. The endogenous
production of TNF-α in intense acute swimming was lower than the
bolus dose of TNF-α used in direct muscle injection [9], indicating that
a low and progressive production of TNF-α would be responsible for
late and progressive muscle hyperalgesia observed in the present
study. The present level of TNF-α is consistent with other models of
hyperalgesia and to the notion that TNF-α production precedes its
hyperalgesic peak [8,26,27,37,38,52,53]. TNF-α also induces indirect
hyperalgesia by contributing to the further production of nociceptive
molecules able to sensitize the nociceptor explaining why the
hyperalgesic effect of TNF-α is not immediate [8,10,52].
TNF-α does not excite group IV neurons, which are sensitive to me-
chanical stimuli [54]. On the other hand, i.m. injection of TNF-α induces
muscle hyperalgesia togetherwith the production of calcitonin-gene re-
lated peptide, nerve growth factor and prostaglandin E2 (PGE2) [9].
These data corroborates previous demonstration that TNF-α induces
mechanical hyperalgesia dependent on the production of other mole-
cules such as PGE2 that is ultimately responsible for nociceptor sensiti-
zation in peripheral inﬂammation [8]. Moreover, TNF-α detection in
the spinal cord indicates that it might have a role as a nociceptor
sensitizing cytokine in this foci and the hyperalgesic role of TNF-α is
not restricted to the muscle tissue. In agreement, peripheral stimuli in-
duce hyperalgesia dependent on activation of spinal cord nociceptive
mechanisms [55–57].
TNF-α is known for its chemoattractant effect [16–18,58] and to
activate NADPH oxidase in recruited neutrophils resulting in the pro-
duction of superoxide anion [19,59]. Therefore, we reason that TNF-α
could be responsible for inﬂammatory cell recruitment and oxidative
stress induced by intense acute swimming in the soleus muscle. In
fact, the treatment with etanercept or deﬁciency of TNFR1 reduced the
increase of MPO activity and GSH depletion induced by intense acute
swimming. MPO activity has been used as a marker of neutrophil re-
cruitment, and was previously used to demonstrate that neutrophils
contribute to inﬂammatory pain by further producing nociceptive
mediators [53,60]. Oxidative stress involves many oxygen and nitrogen
reactive species with an intracellular signaling role that have also been
implicated in the genesis of inﬂammatory and neuropathic pain since
its inhibition by varied strategies reduced nociceptive responses
[20,26,61,62].
The relative amount of antioxidant enzymes present in skeletalmus-
cle ﬁbers differ according to the types of ﬁbers. Slow type I ﬁbers are
more actively recruited during submaximal endurance exercise
compared to the fast type IIX or IIb ﬁbers [63] and increases in muscle
glutathione peroxidase activity are limited to highly oxidative muscles,
which preferably have type I and IIa ﬁbers [64]. Soleus muscle contains
predominantly slow type I (37%) and IIa (38%) myoﬁbers. In turn,
gastrocnemius has predominantly fast type IIb (54%) or IIX (19%)
myoﬁbers, with a small percentage of type I (5%) myoﬁbers [65].
Thus, soleus muscle is considered a highly oxidative muscle com-
pared to gastrocnemius muscle [19,64,65]. Therefore, these myoﬁber
characteristics of soleus (type I and IIa) and gastrocnemius (types
IIb and IIX) corroborates the present data in which the oxidative
stress (reduction of GSH levels) occurred in the soleus, but not in
the gastrocnemius muscle.
The long duration and high intensity of swimming recruited espe-
cially slow oxidative ﬁbers which are resistant to fatigue. It is probable
that during the exercise session, the gastrocnemius muscle was used in
the initial phase of exercise and rapidly entered into fatigue due to the
predominance of fast ﬁbers activity in the initial phase, producing small-
er amounts of chemical mediators and hence causing less oxidativestress. In turn, the soleusmuscle was responsible for producing chemical
mediators such as TNF-α resulting in the recruitment of leukocytes and
generation of oxidative stress with greater intense acute swimming-
induced inﬂammation compared to gastrocnemius muscle due to the
fatigue-resistant ﬁbers. Nevertheless, it is noteworthy to mention that
the participation of gastrocnemius muscle was not completely ruled
out since it might depend on the nature and intensity of exercise and
time point evaluated.
Importantly, the present study used a model of exercise avoiding
stress and hypoalgesia focusing in exercise induced hyperalgesia. To
reach thisﬁne line some studieswere taken into account. Stress is a con-
founding factor in models of swimming capable of generating stress-
induced hyperalgesia, which is inversely related to water temperature
[2,3,6,7,66]. Temperatures between 24 and 26 °C are used in models
to evaluate the mechanisms of stress-induced hyperalgesia and higher
temperatures are not effective to induce stress-induced hyperalgesia
[6,7,66]. In fact, protocols using water at 37 °C are known to induce
hypoalgesia in inﬂammatory and neuropathic pain models [2,3]. There-
fore, an intermediary temperature between those necessary to induce
stress (25 °C) and hypoalgesia (37 °C) was selected for the present
study (31 °C) to focus in exercise-induced hyperalgesia. Additional
concepts corroborate that the present model is not evaluating stress-
induced hyperalgesia or hypoalgesia. Although mice could present
some stress in the initial phase of the swimming exercise, the habitua-
tion of the animal to the condition dissipates the stress [2,3]. In this
sense, a decrease in feces in the water can be observed after the initial
phase (20min) of our intense acute swimming session,which is consid-
ered a valid parameter to indicate habituation [2,3]. Other animalmodel
of swimming, such as forced swim test, is used as an efﬁcient tool to
evaluate abandonment or for screening antidepressant-like activity
[67]. Thesemodels, besides beingused to evaluate depressive behaviors,
often use 5–15 min of swimming session as standard time, with cold
water temperatures (20–24 °C) [68,69], a different protocol from our
model that present long duration (120 min) and intermediate water
temperature to evaluate movement-induced muscle hyperalgesia. Fur-
ther reinforcing this concept, stress-induced hyperalgesia has a limited
duration of few hours, but not prolonged and increasing hyperalgesia
within 1–2 days [70]. Finally, the maintenance of basal serum cortisol
and glucose levels evidenced at the end of the swimming section and
at the peak of hyperalgesia in animals that received one session of
intense acute swimming disproves that stress is responsible for the
hyperalgesia observed in our study.
In fact, we speculate that the present model shows characteristics
closely related to delayed onset muscle soreness (DOMS). DOMS is
an uncomfortable feeling or pain after strenuous exercise session,
especially induced by eccentric contractions, in which the body is
unaccustomed, mainly in untrained individuals, reaching peaks
close to 24–48 h after the exercise session, accompanied by periph-
eral inﬂammatory character, with enhanced cytokine levels [71]. It
should be noted that not only exclusively eccentric exercises induce
DOMS. High intensity and long duration exercises induce DOMS
as demonstrated in long distance runners with peak of muscle
hyperalgesia at 24 h after the exercise [72,73]. Increase in intensity
and duration of exercise results in corresponding increases inmuscle
soreness [74,75]. Thus, the high intensity and long duration of exer-
cise session (2 h of uninterrupted swimming actions) provides a con-
dition compatible with DOMS in the intense acute swimming model.
The uncomfortable pain sensation of DOMS is triggered by move-
ment in a similar fashion to the present model in which the electronic
von Frey was used to induce the movement of mice hind leg, and
since the sensitized muscle presented a lower mechanical threshold
than the intact cutaneous paw skin, a nociceptive behavior could be
detected. The present model adds to the literature by allowing the evalu-
ation of movement-elicited muscle hyperalgesia, complementing the
data using Randall & Selitto test or pressure tests directly applied to the
muscle.
Fig. 7. Schematic representation of the proposed mechanism for the role of TNF-α acting
on TNFR1 receptor in intense acute swimming-induced mechanical hyperalgesia in
mice, a model of delayed onset muscle soreness (DOMS). Intense acute swimming for
120min induces the release of TNF-α in peripheral tissues (soleus, but not gastrocnemius
muscle), resulting in a local inﬂammatory process, due to its chemoattractant and NADPH
oxidase activating actions. This peripheral process leads to TNF-α production in the spinal
cord. As a result of this peripheral and spinal production of TNF-α, there is an increase of
movement-inducedmusclemechanical hyperalgesiawith characteristics of DOMS such as
untrained subjects, high intensity single training session, peak of response between 24 and
48 h and peripheral inﬂammation [71].
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The present study provides evidence on the role of endogenous TNF-
α/TNFR1 in intense acute swimming-induced muscle mechanical
hyperalgesia in mice. There is a muscle speciﬁc role in that the produc-
tion of this cytokine occurs in the soleus, but not gastrocnemiusmuscle.
The soleus muscle is also the foci of inﬂammatory neutrophil recruit-
ment and oxidative stress upon intense exercise. The mechanical
hyperalgesia induced by intense acute swimming depends on peripher-
al (soleus muscle) and central (spinal cord) production of TNF-α. This
advance in the understanding of exercise-induced muscle pain might
contribute to the improvement of the recovery and training of profes-
sional athletes or even individuals with physical limitations related to
age, weight, or skeletal muscle injuries, because the pain limits training
time and increases recovery time. Furthermore, TNF-α/TNFR1 could be
considered a potential target to the prevention of DOMS symptoms. The
proposed participation of TNF-α in intense acute swimming-induced
muscle mechanical hyperalgesia was summarized in Fig. 7.
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